Enfusion, Clearwater and Investment Management

Clearwater agrees to buy investment management platform Enfusion for $1.5B
Clearwater Analytics said it has entered into a definitive agreement to acquire investment management platform Enfusion for $1.5 billion.
Clearwater acquires Enfusion in $1.5B financial software deal
Clearwater Analytics Holdings Inc. today announced plans to acquire Enfusion Inc., a fellow provider of financial software, for $1.5 billion in cash and stock.
Clearwater to acquire Enfusion to expand its Investment Management Platform
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news analysis firm, with a 30-year track record and clients globally. We take pride in covering 400+ technology vendors globally – the largest by any analyst firm in this space.
Clearwater to buy Enfusion for $1.5bn
Clearwater Analytics is building out its investment management platform through the $1.5 billion acquisition of SaaS outfit Enfusion.
Clearwater Analytics Buys Enfusion in $1.5 Bln Deal
Clearwater Analytics struck a deal to buy software company Enfusion in a deal worth $1.5 billion, bolstering its efforts to build a cloud platform for the investment-management industry.
Clearwater Analytics upgraded to Buy at DA Davidson on ‘strategic’ Enfusion deal
DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company’s proposed merger
Clearwater Analytics to buy software maker Enfusion for $1.5 billion to drive global expansion
Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge fund industry.
Clearwater’s Transformative Acquisition of Enfusion Sparks Buy Rating and Growth Optimism
Clearwater Analytics Holdings (CWAN – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst ...
Clearwater Analytics to buy Enfusion for $11.25 a share
Clearwater Analytics (NYSE:CWAN) has agreed to acquire Enfusion (NYSE:ENFN) for $11.25 a share, delivered in an approximately ...
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today announced their entry ...
Traders Magazine4d
Clearwater Analytics to Acquire Enfusion for $1.5 Billion
BOISE, Idaho and CHICAGO, Illinois – January 13, 2025 – Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a ...
Clearwater Analytics upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Michael Infante upgraded Clearwater Analytics (CWAN) to Overweight from Equal Weight with a price target of $34, up from ...
Yahoo Finance3d
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid
Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.
Business Wire4d
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of En…
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are ...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Investors to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between ...